FATE
Price
$1.14
Change
+$0.04 (+3.64%)
Updated
Nov 28, 02:00 PM (EDT)
Capitalization
126.89M
94 days until earnings call
Intraday BUY SELL Signals
ZNTL
Price
$1.43
Change
-$0.01 (-0.69%)
Updated
Nov 28, 02:00 PM (EDT)
Capitalization
103.32M
96 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

FATE vs ZNTL

Header iconFATE vs ZNTL Comparison
Open Charts FATE vs ZNTLBanner chart's image
Fate Therapeutics
Price$1.14
Change+$0.04 (+3.64%)
Volume$77.92K
Capitalization126.89M
Zentalis Pharmaceuticals
Price$1.43
Change-$0.01 (-0.69%)
Volume$1.25K
Capitalization103.32M
FATE vs ZNTL Comparison Chart in %
FATE
Daily Signal:
Gain/Loss:
ZNTL
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
FATE vs. ZNTL commentary
Nov 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FATE is a StrongBuy and ZNTL is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 29, 2025
Stock price -- (FATE: $1.10 vs. ZNTL: $1.44)
Brand notoriety: FATE and ZNTL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FATE: 32% vs. ZNTL: 57%
Market capitalization -- FATE: $126.89M vs. ZNTL: $103.32M
FATE [@Biotechnology] is valued at $126.89M. ZNTL’s [@Biotechnology] market capitalization is $103.32M. The market cap for tickers in the [@Biotechnology] industry ranges from $110.02B to $0. The average market capitalization across the [@Biotechnology] industry is $2.2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FATE’s FA Score shows that 1 FA rating(s) are green whileZNTL’s FA Score has 1 green FA rating(s).

  • FATE’s FA Score: 1 green, 4 red.
  • ZNTL’s FA Score: 1 green, 4 red.
According to our system of comparison, both FATE and ZNTL are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FATE’s TA Score shows that 6 TA indicator(s) are bullish while ZNTL’s TA Score has 4 bullish TA indicator(s).

  • FATE’s TA Score: 6 bullish, 4 bearish.
  • ZNTL’s TA Score: 4 bullish, 7 bearish.
According to our system of comparison, FATE is a better buy in the short-term than ZNTL.

Price Growth

FATE (@Biotechnology) experienced а +4.76% price change this week, while ZNTL (@Biotechnology) price change was +8.27% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.81%. For the same industry, the average monthly price growth was +3.27%, and the average quarterly price growth was +75.56%.

Reported Earning Dates

FATE is expected to report earnings on Mar 02, 2026.

ZNTL is expected to report earnings on Mar 04, 2026.

Industries' Descriptions

@Biotechnology (+8.81% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FATE($127M) has a higher market cap than ZNTL($103M). FATE YTD gains are higher at: -33.333 vs. ZNTL (-52.475). FATE has higher annual earnings (EBITDA): -161.6M vs. ZNTL (-170.37M). ZNTL has more cash in the bank: 303M vs. FATE (223M). ZNTL has less debt than FATE: ZNTL (37.7M) vs FATE (81.3M). ZNTL has higher revenues than FATE: ZNTL (26.9M) vs FATE (8.47M).
FATEZNTLFATE / ZNTL
Capitalization127M103M123%
EBITDA-161.6M-170.37M95%
Gain YTD-33.333-52.47564%
P/E RatioN/AN/A-
Revenue8.47M26.9M31%
Total Cash223M303M74%
Total Debt81.3M37.7M216%
FUNDAMENTALS RATINGS
FATE: Fundamental Ratings
FATE
OUTLOOK RATING
1..100
6
VALUATION
overvalued / fair valued / undervalued
1..100
13
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
FATEZNTL
RSI
ODDS (%)
Bullish Trend 3 days ago
87%
Bullish Trend 3 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
81%
Bearish Trend 3 days ago
88%
Momentum
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
78%
MACD
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
85%
Advances
ODDS (%)
Bullish Trend 5 days ago
84%
Bullish Trend 3 days ago
82%
Declines
ODDS (%)
Bearish Trend 15 days ago
90%
Bearish Trend 9 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
87%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
FATE
Daily Signal:
Gain/Loss:
ZNTL
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RCBC397.003.90
+0.99%
River City Bank
DUVNF0.02N/A
N/A
Peruvian Metals Corp.
IMPJY9.00N/A
N/A
Webuild SpA
SGGKY65.00N/A
N/A
Singapore Technologies Engineering Ltd.
PBKX11.50N/A
N/A
Partners Bank California

ZNTL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZNTL has been loosely correlated with MGNX. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if ZNTL jumps, then MGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZNTL
1D Price
Change %
ZNTL100%
N/A
MGNX - ZNTL
47%
Loosely correlated
+2.07%
SYRE - ZNTL
47%
Loosely correlated
+1.88%
NGNE - ZNTL
46%
Loosely correlated
+1.21%
FATE - ZNTL
45%
Loosely correlated
+3.77%
RXRX - ZNTL
45%
Loosely correlated
+0.92%
More